AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] The Hanover Insurance Group, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Cushman & Wakefield plc (CWK) Form 4: Non-employee director Timothy H. Wennes was granted 11,873 restricted stock units (RSUs) on 01-Aug-2025 under the company’s 2018 Omnibus Non-Employee Director Share and Cash Incentive Plan. Each RSU converts 1-for-1 into ordinary shares.

The RSUs carry a $0 exercise price and will vest and settle on the first anniversary of the grant date, provided Wennes remains on the board. After this transaction he holds 11,873 derivative securities; no open-market purchase or sale occurred, so cash outlay and immediate dilution are zero.

The filing reflects routine director compensation intended to align board and shareholder interests. Because it does not represent a discretionary insider buy or material share issuance, the near-term market impact is considered neutral.

Cushman & Wakefield plc (CWK) Modulo 4: Il direttore non dipendente Timothy H. Wennes ha ricevuto 11.873 unità azionarie vincolate (RSU) il 01 agosto 2025 nell'ambito del Piano Omnibus 2018 per Direttori Non Dipendenti con Azioni e Incentivi in Contanti della società. Ogni RSU si converte 1 a 1 in azioni ordinarie.

Le RSU hanno un prezzo di esercizio di 0 $ e matureranno e saranno liquidate al primo anniversario della data di assegnazione, a condizione che Wennes rimanga nel consiglio di amministrazione. Dopo questa operazione detiene 11.873 titoli derivati; non sono stati effettuati acquisti o vendite sul mercato aperto, quindi la spesa in contanti e la diluizione immediata sono pari a zero.

La comunicazione riflette una normale compensazione per il direttore, volta ad allineare gli interessi del consiglio e degli azionisti. Poiché non rappresenta un acquisto discrezionale da parte di un insider né un'emissione significativa di azioni, l'impatto di mercato a breve termine è considerato neutro.

Cushman & Wakefield plc (CWK) Formulario 4: El director no empleado Timothy H. Wennes recibió 11,873 unidades restringidas de acciones (RSU) el 01 de agosto de 2025 bajo el Plan Omnibus 2018 para Directores No Empleados con Acciones y Bonos en Efectivo de la compañía. Cada RSU se convierte 1 a 1 en acciones ordinarias.

Las RSU tienen un precio de ejercicio de $0 y se consolidarán y liquidarán en el primer aniversario de la fecha de concesión, siempre que Wennes permanezca en la junta. Tras esta transacción, posee 11,873 valores derivados; no hubo compra o venta en el mercado abierto, por lo que el desembolso en efectivo y la dilución inmediata son cero.

La presentación refleja una compensación rutinaria para directores destinada a alinear los intereses de la junta y los accionistas. Como no representa una compra discrecional por parte de un insider ni una emisión material de acciones, el impacto en el mercado a corto plazo se considera neutral.

Cushman & Wakefield plc (CWK) ì–‘ì‹ 4: 비임ì›� ì´ì‚¬ Timothy H. Wennesê°€ 2025ë…� 8ì›� 1ì� 회사ì� 2018ë…� 비임ì›� ì´ì‚¬ ì£¼ì‹ ë°� 현금 ì¸ì„¼í‹°ë¸Œ 종합 계íšì—� ë”°ë¼ 11,873ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 부여받았습니다. ê°� ¸é³§±«µç� 1대 1ë¡� 보통주로 전환ë©ë‹ˆë‹�.

¸é³§±«µç� í–‰ì‚¬ê°€ê²©ì´ 0달러ì´ë©°, 부여ì¼ë¡œë¶€í„� 1주년ì� ë˜ëŠ” ë‚ ì— Wennesê°€ ì´ì‚¬íšŒì— 남아 있는 경우ì—ë§Œ 권리가 확정ë˜ê³  ì •ì‚°ë©ë‹ˆë‹�. ì� 거래 í›� 그는 11,873ê°œì˜ íŒŒìƒ ì¦ê¶Œì� 보유하게 ë˜ë©°, 공개 시장ì—서ì� 매매ëŠ� 없었으므ë¡� 현금 지출과 즉ê°ì ì¸ í¬ì„ 효과ëŠ� 없습니다.

ì� ì‹ ê³ ëŠ� ì´ì‚¬ ë³´ìƒì� 위한 ì¼ìƒì ì¸ 절차ë¡�, ì´ì‚¬íšŒì™€ 주주 ê°� ì´í•´ê´€ê³„를 ì¼ì¹˜ì‹œí‚¤ê¸� 위한 것입니다. ìž„ì˜ì� ë‚´ë¶€ìž� 매수ë‚� 중요í•� ì£¼ì‹ ë°œí–‰ì� 아니므ë¡� 단기 시장 ì˜í–¥ì€ 중립ì �으로 간주ë©ë‹ˆë‹�.

Cushman & Wakefield plc (CWK) Formulaire 4 : Le directeur non salarié Timothy H. Wennes s’est vu attribuer 11 873 unités d’actions restreintes (RSU) le 1er août 2025 dans le cadre du Plan Omnibus 2018 pour les administrateurs non salariés avec actions et incitations en espèces de la société. Chaque RSU se convertit en une action ordinaire à 1 pour 1.

Les RSU ont un prix d’exercice de 0 $ et seront acquises et réglées à la date anniversaire de la remise, à condition que Wennes reste au conseil d’administration. Après cette opération, il détient 11 873 titres dérivés ; aucune transaction sur le marché ouvert n’a eu lieu, donc la dépense en espèces et la dilution immédiate sont nulles.

Cette déclaration reflète une rémunération habituelle des administrateurs visant à aligner les intérêts du conseil et des actionnaires. Comme il ne s’agit ni d’un achat discrétionnaire d’initié ni d’une émission significative d’actions, l’impact à court terme sur le marché est considéré comme neutre.

Cushman & Wakefield plc (CWK) Formular 4: Der nicht geschäftsführende Direktor Timothy H. Wennes erhielt am 01. August 2025 11.873 Restricted Stock Units (RSUs) im Rahmen des Omnibus-2018-Plans für nicht geschäftsführende Direktoren mit Aktien- und Baranreizen des Unternehmens. Jede RSU wandelt sich 1:1 in Stammaktien um.

Die RSUs haben einen Ausübungspreis von 0 $ und werden am ersten Jahrestag des Zuteilungsdatums fällig und abgewickelt, sofern Wennes im Vorstand verbleibt. Nach dieser Transaktion hält er 11.873 derivative Wertpapiere; es gab keinen Kauf oder Verkauf am freien Markt, daher sind Baraufwand und sofortige Verwässerung null.

Die Meldung spiegelt eine routinemäßige Vergütung für Direktoren wider, die darauf abzielt, die Interessen von Vorstand und Aktionären in Einklang zu bringen. Da es sich nicht um einen diskretionären Insider-Kauf oder eine wesentliche Aktienausgabe handelt, wird die kurzfristige Marktwirkung als neutral eingestuft.

Positive
  • 11,873 RSUs granted to a board member, modestly increasing potential insider ownership.
  • One-year vesting encourages director retention and long-term alignment with shareholders.
Negative
  • Grant is not a cash purchase; therefore it lacks the confidence signal of insider buying and has no immediate capital inflow to the company.

Insights

TL;DR: Routine RSU grant; aligns incentives, minimal investor impact.

The Form 4 shows Cushman & Wakefield awarding 11,873 RSUs to director Timothy H. Wennes. The award vests in 12 months, reinforcing board retention and share-price alignment. No cash changed hands and shares are not issued until vesting, so dilution is negligible against the company’s large float. Such scheduled grants are standard practice and do not carry the bullish signal of an open-market purchase. Accordingly, the disclosure is governance-neutral and unlikely to influence valuation or trading volumes.

Cushman & Wakefield plc (CWK) Modulo 4: Il direttore non dipendente Timothy H. Wennes ha ricevuto 11.873 unità azionarie vincolate (RSU) il 01 agosto 2025 nell'ambito del Piano Omnibus 2018 per Direttori Non Dipendenti con Azioni e Incentivi in Contanti della società. Ogni RSU si converte 1 a 1 in azioni ordinarie.

Le RSU hanno un prezzo di esercizio di 0 $ e matureranno e saranno liquidate al primo anniversario della data di assegnazione, a condizione che Wennes rimanga nel consiglio di amministrazione. Dopo questa operazione detiene 11.873 titoli derivati; non sono stati effettuati acquisti o vendite sul mercato aperto, quindi la spesa in contanti e la diluizione immediata sono pari a zero.

La comunicazione riflette una normale compensazione per il direttore, volta ad allineare gli interessi del consiglio e degli azionisti. Poiché non rappresenta un acquisto discrezionale da parte di un insider né un'emissione significativa di azioni, l'impatto di mercato a breve termine è considerato neutro.

Cushman & Wakefield plc (CWK) Formulario 4: El director no empleado Timothy H. Wennes recibió 11,873 unidades restringidas de acciones (RSU) el 01 de agosto de 2025 bajo el Plan Omnibus 2018 para Directores No Empleados con Acciones y Bonos en Efectivo de la compañía. Cada RSU se convierte 1 a 1 en acciones ordinarias.

Las RSU tienen un precio de ejercicio de $0 y se consolidarán y liquidarán en el primer aniversario de la fecha de concesión, siempre que Wennes permanezca en la junta. Tras esta transacción, posee 11,873 valores derivados; no hubo compra o venta en el mercado abierto, por lo que el desembolso en efectivo y la dilución inmediata son cero.

La presentación refleja una compensación rutinaria para directores destinada a alinear los intereses de la junta y los accionistas. Como no representa una compra discrecional por parte de un insider ni una emisión material de acciones, el impacto en el mercado a corto plazo se considera neutral.

Cushman & Wakefield plc (CWK) ì–‘ì‹ 4: 비임ì›� ì´ì‚¬ Timothy H. Wennesê°€ 2025ë…� 8ì›� 1ì� 회사ì� 2018ë…� 비임ì›� ì´ì‚¬ ì£¼ì‹ ë°� 현금 ì¸ì„¼í‹°ë¸Œ 종합 계íšì—� ë”°ë¼ 11,873ê°œì˜ ì œí•œ ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 부여받았습니다. ê°� ¸é³§±«µç� 1대 1ë¡� 보통주로 전환ë©ë‹ˆë‹�.

¸é³§±«µç� í–‰ì‚¬ê°€ê²©ì´ 0달러ì´ë©°, 부여ì¼ë¡œë¶€í„� 1주년ì� ë˜ëŠ” ë‚ ì— Wennesê°€ ì´ì‚¬íšŒì— 남아 있는 경우ì—ë§Œ 권리가 확정ë˜ê³  ì •ì‚°ë©ë‹ˆë‹�. ì� 거래 í›� 그는 11,873ê°œì˜ íŒŒìƒ ì¦ê¶Œì� 보유하게 ë˜ë©°, 공개 시장ì—서ì� 매매ëŠ� 없었으므ë¡� 현금 지출과 즉ê°ì ì¸ í¬ì„ 효과ëŠ� 없습니다.

ì� ì‹ ê³ ëŠ� ì´ì‚¬ ë³´ìƒì� 위한 ì¼ìƒì ì¸ 절차ë¡�, ì´ì‚¬íšŒì™€ 주주 ê°� ì´í•´ê´€ê³„를 ì¼ì¹˜ì‹œí‚¤ê¸� 위한 것입니다. ìž„ì˜ì� ë‚´ë¶€ìž� 매수ë‚� 중요í•� ì£¼ì‹ ë°œí–‰ì� 아니므ë¡� 단기 시장 ì˜í–¥ì€ 중립ì �으로 간주ë©ë‹ˆë‹�.

Cushman & Wakefield plc (CWK) Formulaire 4 : Le directeur non salarié Timothy H. Wennes s’est vu attribuer 11 873 unités d’actions restreintes (RSU) le 1er août 2025 dans le cadre du Plan Omnibus 2018 pour les administrateurs non salariés avec actions et incitations en espèces de la société. Chaque RSU se convertit en une action ordinaire à 1 pour 1.

Les RSU ont un prix d’exercice de 0 $ et seront acquises et réglées à la date anniversaire de la remise, à condition que Wennes reste au conseil d’administration. Après cette opération, il détient 11 873 titres dérivés ; aucune transaction sur le marché ouvert n’a eu lieu, donc la dépense en espèces et la dilution immédiate sont nulles.

Cette déclaration reflète une rémunération habituelle des administrateurs visant à aligner les intérêts du conseil et des actionnaires. Comme il ne s’agit ni d’un achat discrétionnaire d’initié ni d’une émission significative d’actions, l’impact à court terme sur le marché est considéré comme neutre.

Cushman & Wakefield plc (CWK) Formular 4: Der nicht geschäftsführende Direktor Timothy H. Wennes erhielt am 01. August 2025 11.873 Restricted Stock Units (RSUs) im Rahmen des Omnibus-2018-Plans für nicht geschäftsführende Direktoren mit Aktien- und Baranreizen des Unternehmens. Jede RSU wandelt sich 1:1 in Stammaktien um.

Die RSUs haben einen Ausübungspreis von 0 $ und werden am ersten Jahrestag des Zuteilungsdatums fällig und abgewickelt, sofern Wennes im Vorstand verbleibt. Nach dieser Transaktion hält er 11.873 derivative Wertpapiere; es gab keinen Kauf oder Verkauf am freien Markt, daher sind Baraufwand und sofortige Verwässerung null.

Die Meldung spiegelt eine routinemäßige Vergütung für Direktoren wider, die darauf abzielt, die Interessen von Vorstand und Aktionären in Einklang zu bringen. Da es sich nicht um einen diskretionären Insider-Kauf oder eine wesentliche Aktienausgabe handelt, wird die kurzfristige Marktwirkung als neutral eingestuft.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lowsley Denise

(Last) (First) (Middle)
C/O THE HANOVER INSURANCE GROUP, INC.
440 LINCOLN STREET

(Street)
WORCESTER MA 01653

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HANOVER INSURANCE GROUP, INC. [ THG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 M 5,626 A $118.54 10,745.028(1) D
Common Stock 08/01/2025 S 5,626 D $168.15 5,119.028(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock Option (right to buy) $118.54 08/01/2025 M 5,626 (2) 02/28/2030 Common Stock 5,626 $0 0 D
Explanation of Responses:
1. Includes 73 shares acquired pursuant to The Hanover Insurance Group Inc.'s 2023 Employee Stock Purchase Plan on June 30, 2025.
2. The option, representing the right to purchase a total of 5,626 shares, vested 1/3 on each of 2/28/21, 2/28/22 and 2/28/23.
/s/ Lindsay L. Katz pursuant to Confirming Statement 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many RSUs did Timothy H. Wennes receive according to CWK's Form 4?

The filing reports a grant of 11,873 restricted stock units.

When do the RSUs granted to CWK director Wennes vest?

They vest and settle one year after the 01-Aug-2025 grant date, subject to continued board service.

Did the director purchase CWK shares with cash?

No. The transaction is an equity grant at $0 cost, not an open-market purchase.

What is the conversion ratio for the RSUs reported in the Form 4?

Each RSU converts on a 1-for-1 basis into an ordinary share of Cushman & Wakefield.

Does this Form 4 indicate a significant change in insider ownership at CWK?

No material change; the grant adds potential future shares but is routine director compensation.
Hanover Insuranc

NYSE:THG

THG Rankings

THG Latest News

THG Latest SEC Filings

THG Stock Data

6.12B
35.59M
0.82%
90.48%
1.61%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
United States
WORCESTER